Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

7.14
+0.17502.51%
Volume:496.75K
Turnover:3.50M
Market Cap:1.18B
PE:-68.35
High:7.15
Open:7.03
Low:6.90
Close:6.96
52wk High:10.08
52wk Low:3.45
Shares:165.92M
Float Shares:159.00M
Volume Ratio:0.86
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1044
EPS(LYR):-0.3736
ROE:-617.16%
ROA:2.88%
PB:-1374.99
PE(LYR):-19.10

Loading ...

Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 10, 2025

Correspondence

Form CORRESP - Correspondence
May 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]